Your browser doesn't support javascript.
loading
Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.
Alessi, Marie-Christine; Gaudin, Christophe; Grosjean, Philippe; Martin, Valérie; Timsit, Serge; Mahagne, Marie-Hélène; Larrue, Vincent; Sibon, Igor; Zuber, Mathieu; Brouns, Raf; Montaner, Joan; Castellanos, Mar; Donazzolo, Yves; Cho, Tae-Hee; Suissa, Laurent; Mechtouff, Laura; Derex, Laurent; Suchon, Pierre; Mezzapesa, Anna; Nighoghossian, Norbert.
Affiliation
  • Alessi MC; Laboratory Haemostasis, Inserm UMR 1062, Inra UMR 1260, Aix Marseille University, Marseille, France.
Cerebrovasc Dis ; 42(5-6): 404-414, 2016.
Article in En | MEDLINE | ID: mdl-27387478
Subject(s)
Search on Google
Print
XML
PubMed Links

Database: MEDLINE Main subject: Thrombolytic Therapy / Brain Ischemia / Tissue Plasminogen Activator / Stroke / Carboxypeptidase B2 / Fibrinolytic Agents Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2016 Type: Article
Search on Google
Print
XML
PubMed Links

Database: MEDLINE Main subject: Thrombolytic Therapy / Brain Ischemia / Tissue Plasminogen Activator / Stroke / Carboxypeptidase B2 / Fibrinolytic Agents Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2016 Type: Article